Shine Pharmaceuticals Limited, a active public limited company, was established on 17 August 1994 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1994PLC022787. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.38 Cr.
Formerly known as Shine Pharmaceuticals Private Limited. It upholds a compliant status. Employing 780 professional, Its leadership includes Tejal Ashish Parikh (Director), Hiranmay Saha (Director), Samir Chakraborty (Managing Director). Past directors included Tejal Ashish Parikh, Noel Bhattacharjee, Rangoli Saurav Gada. It holds ₹0.68 M open charges and ₹9.30 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 309-310, Dwarkesh Complex, 3Rd Floor, Sun Pharma Road, Off. Old Padra Road, At, Ladara,, Vadodara, Gujarat, 390012.
U24231GJ1994PLC022787
022787
17 August 1994
₹5.00 Cr
₹3.38 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Shine Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tejal Ashish Parikh | Director | 30 Mar 2024 | Current |
| Hiranmay Saha | Director | 30 May 1996 | Current |
| Samir Chakraborty | Managing Director | 01 Apr 2005 | Current |
| Rangoli Saurav Gada | Director | 25 Mar 2023 | Current |
| Aloka Saha | Whole-Time Director | 30 May 1996 | Current |
| Pradeep Vishambhar Agrawal | Whole-Time Director | 01 Jul 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Whole-Time Director | 21 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 01 Apr 2008 | Past |
| Pramod Abcsdd | Director | 01 Apr 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shine Pharmaceuticals Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 5.27% decrease. The company also saw a substantial improvement in profitability, with a 46.63% increase in profit. The company's net worth Soared by an impressive increase of 22.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Shine Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹680,000.00
₹92,988,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2019 | Axis Bank Limited | ₹0.68 M | Open |
| 24 Dec 2020 | Others | ₹2.00 Cr | Satisfied |
| 26 Sep 2019 | Others | ₹7.50 M | Satisfied |
| 03 Jan 2004 | Bank Of Baroda | ₹3.55 Cr | Satisfied |
| 05 Jul 2003 | Bank Of Baroda | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Shine Pharmaceuticals has a workforce of 780 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shine Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shine Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Shine Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
Tejal Ashish Parikh was appointed as a Director was appointed as a Director on 30 Mar 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
A charge registered on 24 Dec 2020 via Charge ID 100397788 with Others was fully satisfied on 21 Mar 2024. was recorded as a recent event.
Rangoli Saurav Gada was appointed as a Director was appointed as a Director on 25 Mar 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.
The activity A charge registered on 26 Sep 2019 via Charge ID 100294266 with Others was fully satisfied on 30 Mar 2022. was completed.
The CIN of Shine Pharmaceuticals Limited is U24231GJ1994PLC022787.
Shine Pharmaceuticals Limited is headquartered at 309-310, Dwarkesh Complex, 3Rd Floor, Sun Pharma Road, Off. Old Padra Road, At, Ladara,, Vadodara, Gujarat, 390012.
Shine Pharmaceuticals Limited was incorporated on 17 August 1994.
The current directors of Shine Pharmaceuticals Limited are
The primary industry of Shine Pharmaceuticals Limited is Manufacturing.
Shine Pharmaceuticals Limited is unlisted.
The authorized capital of Shine Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹3.38 Cr.
The compliance status of Shine Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX